Piper Sandler

Congratulations to Minnesota-based 4C Medical Technologies, Inc. on their recent $175M Series D financing, led by Boston Scientific. 4C Medical is the developer of the AltaValve™ System, a device developed to treat mitral valve regurgitation (“MR”). The proceeds from this financing will be utilized to support and accelerate the company’s ongoing global pivotal trial. MR is the most common and consequential coronary valvular (structural heart) disease with ~5 million people in the U.S. currently suffering from moderate to severe MR. The AltaValve represents a paradigm shift in MR treatment as its atrial fixation bypasses the complexity and variability of the mitral annulus and left ventricle preserving critical cardiac structures and native hemodynamics to provide a treatment option for a broad number of MR patients.   To learn more or to connect with our team, please visit https://lnkd.in/g7Vi_gAN Jon Salveson, Daniel Schkrohowsky, Nicholas Gilbert

We are proud to celebrate our food & beverage team’s success in 2024 and are excited about the momentum heading into 2025! Learn more about us at pipersandler.com/consumer

Join us for the latest episode of What's Next for Markets, where Michael Kantrowitz, CFA and Stephen Gregory discuss A.I. & NVDA with Piper Sandler semiconductor analyst, Harsh Kumar. Harsh has covered the semiconductor industry since the mid-1990s. Visit https://lnkd.in/gK546dZT to learn more.

Congratulations to our newly promoted colleagues! They have consistently demonstrated outstanding performance, client dedication, leadership skills and commitment to our Guiding Principles. We are grateful to have you on the team. Tag someone to celebrate in the comments!

Congratulations to OrganOx on their $142 million primary and secondary equity financing to accelerate growth opportunities for their metra® platform technology in the large and high growth organ technology global market. OrganOx is a commercial stage organ technology company, spun out of the University of Oxford in 2008, dedicated to developing technologies to improve outcomes for patients with acute or chronic organ failure. The company’s platform technology, metra®, is a normothermic machine perfusion (NMP) system that is approved in the U.S., Europe, Canada and Australia. It has been utilized in over 5,000 liver transplants to date to keep donor livers in a metabolically active state outside the body so that functional assessment of the organ can be performed prior to transplant, leading to an increased number of organs available for transplant.  Learn more about the Piper Sandler healthcare team: https://lnkd.in/g7Vi_gAN J.P. Peltier, Charles Hamilton, Chad Schwarze, Chris Louk

Piper Sandler is pleased to announce the addition of Mary Stone as a managing director and co-head of the structured finance group alongside Chris Howley. She will be based in the New York office. “We are ecstatic to have Mary on the Piper Sandler platform. Mary’s deep expertise within multiple securitization markets, whole loan trading, and deal structuring will immediately benefit our clients,” said Michael Piper, managing director and head of non-depository fixed income at Piper Sandler. View the press release to learn more: https://lnkd.in/g8pNzp-j

Piper Sandler is pleased to announce the addition of Ahsan Jamil Khan as a managing director along with Jonathan Hartland and Andrew Fair as directors to its private capital advisory investment banking group. The additions expand and reinforce the private capital advisory business’s GP advisory and distribution capabilities in the Middle East, Europe and North America. “We are excited to strengthen our service offerings in both EMEA and North America. Specifically, expanding our footprint in EMEA is a key strategic priority for the firm, as the region presents significant opportunities for our private capital advisory business. Khan and Hartland enhance our ability to execute complex fundraising mandates with on-the-ground market intelligence and broaden our reach among European and Middle Eastern GPs and investors. Our expanded coverage will allow us to better advise clients on tailored market entry strategies, helping them access new sources of capital in a rapidly evolving investor landscape,” said Ryan Schlitt, head of private capital advisory at Piper Sandler. View the press release to learn more: pipersandler.com/news

Congratulations to Paragon 28 on their recently announced sale to Zimmer Biomet, anticipated to close in the first half of 2025. Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic segment and is dedicated to improving patient lives. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent and reproducible.   Learn more about the Piper Sandler healthcare team: https://lnkd.in/gvR_WrXv J.P. Peltier, Bart Federak, Daniel Schkrohowsky

Jeremy Goebel, the head of U.S. Government bond trading at Piper Sandler, sits down with The Minnesota Star Tribune to discuss the bond market.

Piper Sandler is excited to announce our eleventh Bi-Annual Cultural Leadership Award recipient: Karin Renier. The award highlights the individuals in our firm who act as a cultural ambassador by consistently demonstrating inclusive partnership, drive, positivity and creativity through an entrepreneurial spirit. “Karin creates space for others to lead confidently, encouraging innovation and exploration. She enables growth and development at every level by putting individuals in a position to succeed,” said a colleague. Congratulations Karin!